OBJECTIVE: 1) Determine the incidence of HPV in confirmed unknown primary squamous cell carcinomas of the head and neck (HNSCC). 2) Assess whether HPV status influenced the survival time of patients with unknown primary HNSCC. METHOD: This retrospective study investigates patients from the Tumor Registry and PET database between 2002 and 2009, who underwent neck dissections for unknown primaries of the HNSCC, after complete work up. The INFORM HPV III Family 16 (B) probe was used for chromogenic in-situ hybridization on paraffin embedded tissues to identify all relevant HPV genotypes. HPV status and survival time were compared and then each compared with age, tobacco use, and nodal stage.
RESULTS:
We identified 22 patients with unknown primaries, ages 48-88 years old. 5 out of 22 (23%) of the samples were HPVϩ. There was no significant difference in age (pϭ0.49) or nodal stage (pϭ0.62) between HPV ϩ and patients. The only significant finding was that all non-smokers were HPVϩ (pϭ0.009). Survival time was not significantly associated with HPV status (pϭ0.94), age (pϭ0.6), tobacco use (pϭ 0.82), or nodal stage (pϭ 0.14). CONCLUSION: Twenty-three percent of the neck metastasis in confirmed unknown primary HNSCC were HPVϩ. We did not observe an increased survival time with these HPVϩ tumors. These HPV ϩ cases are likely to have their occult primaries in the oropharynx and would preferentially benefit from tonsillectomies and aggressive tongue base biopsies. This could spare HPV-tumors the morbidity of tonsillectomy and HPVϩ patients the morbidity associated with radiotherapy to all of Waldeyer's ring.
Increased Expression of c-Kit in Mucosal Melanoma
Calvin Wei, MD (presenter); Kepal Patel, MD; Beverly Wang, MD OBJECTIVE: Recent studies have shown that Th-17 related genes are expressed in cutaneous melanomas. Gene mutations of CD117, also known as c-kit, a tyrosine kinase receptor, have also been found in cutaneous and mucosal melanomas. The objective of our study was to study the expression of Th-17related genes and c-kit in head and neck mucosal melanomas. METHOD: Thirty-eight paraffin-embedded mucosal melanoma sections from the nasal cavities and paranasal sinuses were analyzed. Nine cases were extracted with TRIzol after deparaffinizing with xylene and first strand cDNA synthesis was performed. PCR for hGAPDH was used as an internal control. Two rounds of nested PCR for IL17A/B/C/D/E/F, RORgammaT, FoxP3, CD27, PLZF, CD70 and CTLA-4 were performed. Twenty-nine cases were stained by automated immunohistochemistry using a pre-diluted monoclonal c-kit antibody (clone 9.7, Ventana Medical Systems, Tucson, AZ) and by a standard avidin-biotin complex utilizing the BenchMark XT system (Ventana Medical Systems, Tucson, AZ). RESULTS: Expression of Th-17 related genes was detected. We found 2/9 cases positive for CTLA4, IL17C, IL17D, IL17E, RORgamma T and FoxP3; 4/9 for CD27 and IL17A; 6/9 for IL17B; and 1/9 for CD70. No expression was seen for PLZF and IL17F. Increased c-kit expression was identified in 25 of the 29 (86.2%) mucosal melanoma samples. Five tumors were diffusely positive (4ϩ), 9 were positive (3ϩ), 7 were patchy positive (2ϩ), and 4 showed focal and weak (1ϩ) staining.
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